Development of a Predictive Model to Induce Atherogenesis and Hepato-Renal Impairment in Female Rats

Therapeutic approaches for the treatment of dyslipidemia and atherosclerosis have radically changed in recent decades. Part of this advance undeniably stems from basic biomedical research that has provided a better understanding and identification of new therapeutic targets. The aim of this work was...

Full description

Bibliographic Details
Main Authors: Lucas Pires Guarnier, Paulo Vitor Moreira Romão, Rhanany Alan Calloi Palozi, Aniely Oliveira Silva, Bethânia Rosa Lorençone, Aline Aparecida Macedo Marques, Ariany Carvalho dos Santos, Roosevelt Isaias Carvalho Souza, Karine Delgado Souza, Emerson Luiz Botelho Lourenço, Arquimedes Gasparotto Junior
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/9/11/664
_version_ 1818361536142376960
author Lucas Pires Guarnier
Paulo Vitor Moreira Romão
Rhanany Alan Calloi Palozi
Aniely Oliveira Silva
Bethânia Rosa Lorençone
Aline Aparecida Macedo Marques
Ariany Carvalho dos Santos
Roosevelt Isaias Carvalho Souza
Karine Delgado Souza
Emerson Luiz Botelho Lourenço
Arquimedes Gasparotto Junior
author_facet Lucas Pires Guarnier
Paulo Vitor Moreira Romão
Rhanany Alan Calloi Palozi
Aniely Oliveira Silva
Bethânia Rosa Lorençone
Aline Aparecida Macedo Marques
Ariany Carvalho dos Santos
Roosevelt Isaias Carvalho Souza
Karine Delgado Souza
Emerson Luiz Botelho Lourenço
Arquimedes Gasparotto Junior
author_sort Lucas Pires Guarnier
collection DOAJ
description Therapeutic approaches for the treatment of dyslipidemia and atherosclerosis have radically changed in recent decades. Part of this advance undeniably stems from basic biomedical research that has provided a better understanding and identification of new therapeutic targets. The aim of this work was to develop a model to induce atherogenesis and hepato-renal impairment in female Wistar rats. The following groups received the respective treatments for 60 days: control animals, non-ovariectomized rats that received an atherogenic diet (NEAD), ovariectomized rats that received an atherogenic diet (NOAD), non-ovariectomized rats that received an atherogenic diet and oral N&#969;-nitro-<span style="font-variant: small-caps;">l</span>-arginine methyl ester hydrochloride (<span style="font-variant: small-caps;">l</span>-NAME; LEAD), and ovariectomized rats that received an atherogenic diet and oral <span style="font-variant: small-caps;">l</span>-NAME (LOAD). Animals in the NEAD, NOAD, LEAD, and LOAD groups also received methimazole and cholecalciferol daily. Urinary, biochemical, hemodynamic, and electrocardiographic parameters and renal function were assessed. Samples of the liver, heart, kidney, and arteries were collected to investigate redox status and perform histopathological analyses. All of the groups developed dyslipidemia and hepatic steatosis. Only the NEAD group developed arterial lesions that were compatible with fatty streaks. Renal function was significantly impaired in the LEAD and NOAD groups. These results indicate a viable alternative to induce atherogenesis and hepato-renal impairment in female rats.
first_indexed 2024-12-13T21:18:14Z
format Article
id doaj.art-e4a91c2dca6744cea4cf538aabff7ca3
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-12-13T21:18:14Z
publishDate 2019-10-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-e4a91c2dca6744cea4cf538aabff7ca32022-12-21T23:31:12ZengMDPI AGBiomolecules2218-273X2019-10-0191166410.3390/biom9110664biom9110664Development of a Predictive Model to Induce Atherogenesis and Hepato-Renal Impairment in Female RatsLucas Pires Guarnier0Paulo Vitor Moreira Romão1Rhanany Alan Calloi Palozi2Aniely Oliveira Silva3Bethânia Rosa Lorençone4Aline Aparecida Macedo Marques5Ariany Carvalho dos Santos6Roosevelt Isaias Carvalho Souza7Karine Delgado Souza8Emerson Luiz Botelho Lourenço9Arquimedes Gasparotto Junior10Laboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS 79825-070, BrazilLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS 79825-070, BrazilLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS 79825-070, BrazilLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS 79825-070, BrazilLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS 79825-070, BrazilLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS 79825-070, BrazilLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS 79825-070, BrazilLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS 79825-070, BrazilLaboratory of Preclinical Research of Natural Products, Paranaense University (UNIPAR), Umuarama, PR 87502-210, BrazilLaboratory of Preclinical Research of Natural Products, Paranaense University (UNIPAR), Umuarama, PR 87502-210, BrazilLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS 79825-070, BrazilTherapeutic approaches for the treatment of dyslipidemia and atherosclerosis have radically changed in recent decades. Part of this advance undeniably stems from basic biomedical research that has provided a better understanding and identification of new therapeutic targets. The aim of this work was to develop a model to induce atherogenesis and hepato-renal impairment in female Wistar rats. The following groups received the respective treatments for 60 days: control animals, non-ovariectomized rats that received an atherogenic diet (NEAD), ovariectomized rats that received an atherogenic diet (NOAD), non-ovariectomized rats that received an atherogenic diet and oral N&#969;-nitro-<span style="font-variant: small-caps;">l</span>-arginine methyl ester hydrochloride (<span style="font-variant: small-caps;">l</span>-NAME; LEAD), and ovariectomized rats that received an atherogenic diet and oral <span style="font-variant: small-caps;">l</span>-NAME (LOAD). Animals in the NEAD, NOAD, LEAD, and LOAD groups also received methimazole and cholecalciferol daily. Urinary, biochemical, hemodynamic, and electrocardiographic parameters and renal function were assessed. Samples of the liver, heart, kidney, and arteries were collected to investigate redox status and perform histopathological analyses. All of the groups developed dyslipidemia and hepatic steatosis. Only the NEAD group developed arterial lesions that were compatible with fatty streaks. Renal function was significantly impaired in the LEAD and NOAD groups. These results indicate a viable alternative to induce atherogenesis and hepato-renal impairment in female rats.https://www.mdpi.com/2218-273X/9/11/664atherosclerosisdyslipidemiahepatic steatosiskidney failure
spellingShingle Lucas Pires Guarnier
Paulo Vitor Moreira Romão
Rhanany Alan Calloi Palozi
Aniely Oliveira Silva
Bethânia Rosa Lorençone
Aline Aparecida Macedo Marques
Ariany Carvalho dos Santos
Roosevelt Isaias Carvalho Souza
Karine Delgado Souza
Emerson Luiz Botelho Lourenço
Arquimedes Gasparotto Junior
Development of a Predictive Model to Induce Atherogenesis and Hepato-Renal Impairment in Female Rats
Biomolecules
atherosclerosis
dyslipidemia
hepatic steatosis
kidney failure
title Development of a Predictive Model to Induce Atherogenesis and Hepato-Renal Impairment in Female Rats
title_full Development of a Predictive Model to Induce Atherogenesis and Hepato-Renal Impairment in Female Rats
title_fullStr Development of a Predictive Model to Induce Atherogenesis and Hepato-Renal Impairment in Female Rats
title_full_unstemmed Development of a Predictive Model to Induce Atherogenesis and Hepato-Renal Impairment in Female Rats
title_short Development of a Predictive Model to Induce Atherogenesis and Hepato-Renal Impairment in Female Rats
title_sort development of a predictive model to induce atherogenesis and hepato renal impairment in female rats
topic atherosclerosis
dyslipidemia
hepatic steatosis
kidney failure
url https://www.mdpi.com/2218-273X/9/11/664
work_keys_str_mv AT lucaspiresguarnier developmentofapredictivemodeltoinduceatherogenesisandhepatorenalimpairmentinfemalerats
AT paulovitormoreiraromao developmentofapredictivemodeltoinduceatherogenesisandhepatorenalimpairmentinfemalerats
AT rhananyalancalloipalozi developmentofapredictivemodeltoinduceatherogenesisandhepatorenalimpairmentinfemalerats
AT anielyoliveirasilva developmentofapredictivemodeltoinduceatherogenesisandhepatorenalimpairmentinfemalerats
AT bethaniarosalorencone developmentofapredictivemodeltoinduceatherogenesisandhepatorenalimpairmentinfemalerats
AT alineaparecidamacedomarques developmentofapredictivemodeltoinduceatherogenesisandhepatorenalimpairmentinfemalerats
AT arianycarvalhodossantos developmentofapredictivemodeltoinduceatherogenesisandhepatorenalimpairmentinfemalerats
AT rooseveltisaiascarvalhosouza developmentofapredictivemodeltoinduceatherogenesisandhepatorenalimpairmentinfemalerats
AT karinedelgadosouza developmentofapredictivemodeltoinduceatherogenesisandhepatorenalimpairmentinfemalerats
AT emersonluizbotelholourenco developmentofapredictivemodeltoinduceatherogenesisandhepatorenalimpairmentinfemalerats
AT arquimedesgasparottojunior developmentofapredictivemodeltoinduceatherogenesisandhepatorenalimpairmentinfemalerats